-
Ipsen
- Directeur de l’unité Neurologie et Esthétique
Boulogne-Billancourt
2014 - 2016
• Elaboration de la stratégique du produit DYSPORT® et offre commerciale de l'unité
• Définir les plans d'actions annuels (promotion des produits, marchés à investir, portefeuille futur, développement cliniques)
• Elaboration et gestion des budgets marketing et organisationnels de la force de vente
• Responsable du management de l’équipe marketing et ventes (22 personnes)
• Organisation de la force commerciale de l'entreprise (déploiement du réseau, formations commerciales, réorganisation géographique)
• Atteinte de l’objectif de croissance du marché privé de 32% en 2015
• Création du premier consensus médical en paralysie cérébrale ainsi que sa publication en 2016
-
Ipsen
- Directeur des ventes et marketing de l’unité Neurologie et Esthétique
Boulogne-Billancourt
2010 - 2014
• Développement d’actions de gestion de ressources humaines (recrutement, plan de développement, ajustement de salaires)
• Organisation du service commercial (réunions, notes, directives, procédures) et échange des informations avec les commerciaux
• Responsable du management de l’équipe de ventes (20 personnes)
• Coordination l'activité des commerciaux et leur apporter un appui technique
• Suivi et analyse les données d'activité du service ou de la structure et proposer des axes d'évolution
• Elaboration d’un partenariat avec Galderma et de nouveaux distributeurs pour re-dynamiser les ventes esthétiques
-
IPSEN Biotech Pharma Inc (Paris -France)
- International Group Manager Biotech Range
2008 - 2010
Intercontinental Operations: Central &South America, Middle East, North Africa, Asia, Russia, Australia
o Ensuring the product management of DYSPORT® BoNT-A- Neurology & Aesthetic indications
+++ Organizing international scientific expertise sharing and training
+++ Defining the strategic communication axes and elaborating promotional kits for the zone
+++ Defining and implementing business development opportunities & sales force effectiveness
+++ Developing and cultivating close contact with main international opinion leaders
+++ Supervising and validating local marketing plans with countries General Managers
o Launching new company approach through worldwide Cosmetic Consensus with Galderma and Medicis
Suggesting the orientation of clinical and industrial development (e.g. China & other formulations)
o Analyzing & challenging product budget resource allocation and countries P&L
o Directing all qualitative and quantitative market research relative to develop product business penetration
o Directing the strategic creation of all promotional material content across countries
o Developing multimedia education opportunities, as a avenue for Continuing Medical Education programs
-
Boehringer Ingelheim France
- Product Manager in Respiratory
Paris Cedex 13
2005 - 2007
--------Preparation and launch of largest and most strategic 2006 new respiratory product introduction for BIF (budget exceeded by 20%)
o Development of brand plans and strategies concerning General Practitioners and Pharmacists.
o Development of marketing campaigns for 2 different GP field forces (2x250 sales representatives)
o Organization and management of Respiratory symposia, congresses (Medec Award 2006)
o Launch of the first trimestrial respiratory posology and hospital sampling for COPD
o Working closely with international Respiratory Key Opinion Leaders
o Supervision of respiratory clinical trials among General Practitioners
o Management and maximization of co-promotion with Pfizer
o Creation of avant-garde multimedia CME tools for sales reps (Festival des Entretiens de Bichat Award 2006)
--------Responsible for the management and growth of respiratory portfolio
(SPIRIVA®, BRONCHODUAL®, COMBIVENT® & ATROVENT®)
-
Boehringer Ingelheim, U.S.A
- Junior Product Manager in Respiratory
2003 - 2005
--------Prepared and launched 2004 largest US respiratory product introduction for BIPI: SPIRIVA®
o Served as central coordinator for development of timelines, key milestones and marketing communications (brochures, visual aids, patient kits, advertising, promotion, public relations)
o Management and maximization of co-promotion with Pfizer
o Organized internal communication event for SPIRIVA® HandiHaler® launch (3,000 people)
-Led development of strategic plan to expand and develop product offerings specific to the Hispanic market
o Leveraged Spanish speaking skills to build promotional and educational tools for physicians and ethnic consumers
o Organized and managed national sales conventions
--------Implemented re-launch of website for share-leading brands, COMBIVENT® and ATROVENT®, to communicate new positioning which helped grow revenues over 10% vs YAG
o Created industry-first, online video education tool detailing proper technique for use of a respiratory treatment
--------Assisted with planning and creation of marketing tools for ATROVENT® HFA US launch 2005
